Clinical Trials Directory

Trials / Completed

CompletedNCT00664053

Effects of DHEA/Exercise on Bone, Muscle and Balance

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
99 (actual)
Sponsor
National Aeronautics and Space Administration (NASA) · Federal
Sex
Female
Age
65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine whether muscle strength and balance will improve in women with frailty selected for dehydroepiandrosterone sulfate (DHEAS) levels below 550 ng/dl treated with DHEAS supplementation and Hatha yoga. Investigators believe the effects of both treatments will improve outcomes more than either treatment alone and may be additive; in addition, lean body mass, skeletal muscle mass, markers of bone turnover and physical performance will improve following treatment with DHEA and/or yoga.

Detailed description

Dehydroepiandrosterone (DHEAS) and yoga may mitigate or reverse the effects of aging and frailty on bone, muscle and balance loss. The mechanism of the effects may be direct - working through androgen or estrogen receptors in bone, muscle or brain. Or the effects may be indirect, countering effects of the stress response. The specific aims of this study are: 1. To determine the effects of dehydroepiandrosterone sulfate (DHEAS) supplementation and/or Hatha yoga on muscle strength, balance, body composition and physical performance measures over 6 months in women with osteopenia and some degree of frailty 2. To determine the effect of dehydroepiandrosterone sulfate (DHEAS) supplementation and/or Hatha yoga on function (physical and cognitive), bone metabolism, and cardiovascular risk factors.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDHEA50mg daily for 6 months
BEHAVIORALYoga2 sessions per week for 6 months
DIETARY_SUPPLEMENTPlaceboPlacebo supplement every day for 6 months
BEHAVIORALAerobicsWalking/chair aerobics program 2 sessions per week for 6 months

Timeline

Start date
2004-10-01
Primary completion
2006-10-01
Completion
2006-10-01
First posted
2008-04-22
Last updated
2008-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00664053. Inclusion in this directory is not an endorsement.